Immunome to Present at Upcoming March Conferences [Yahoo! Finance]
Immunome, Inc. (IMNM)
Company Research
Source: Yahoo! Finance
best-in-class targeted cancer therapies, today announced that it will participate in the following investor conferences in March 2025: TD Cowen 45th Annual Health Care Conference Conference Dates: March 3-5, 2025 Presentation Date/Time: March 4, 2025, 1:10 p.m. ET Leerink Partners Global Healthcare Conference 2025 Conference Dates: March 10-12, 2025 Presentation Date/Time: March 10, 2025, 1:40 p.m. ET Live webcast links for both presentations will be available on the events tab of Immunome's investor website. Replay links of the presentations will also be available on the website for 30 days following the live broadcast. About Immunome Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercializati
Show less
Read more
Impact Snapshot
Event Time:
IMNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNM alerts
High impacting Immunome, Inc. news events
Weekly update
A roundup of the hottest topics
IMNM
News
- Immunome: Maintaining "Strong Buy" On Successful RINGSIDE Trial With Varegacestat [Seeking Alpha]Seeking Alpha
- Immunome prices $400M stock offering at $21.50 a share [Seeking Alpha]Seeking Alpha
- Stock Market Today: Russell 2000, Nasdaq Saddle Tech Pullback Ahead of Big Week of Data [Yahoo! Finance]Yahoo! Finance
- Immunome Announces Pricing of Public Offering of Common Stock [Yahoo! Finance]Yahoo! Finance
- Immunome Announces Pricing of Public Offering of Common StockBusiness Wire
IMNM
Earnings
- 8/6/25 - Beat
IMNM
Sec Filings
- 12/18/25 - Form 4
- 12/17/25 - Form 8-K
- 12/17/25 - Form 424B5
- IMNM's page on the SEC website